SOBHANI, NAVID
SOBHANI, NAVID
Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute
Advances in systemic therapy for malignant mesothelioma: Future perspectives
2017-01-01 Sobhani, Navid; Corona, Silvia Paola; Bonazza, Deborah; Ianza, Anna; Pivetta, Tania; Roviello, Giandomenico; Cortale, Maurizio; Guglielmi, Alessandra; Zanconati, Fabrizio; Generali, Daniele
Advances in systemic therapy for metastatic breast cancer: future perspectives
2017-01-01 Corona, S. P.; Sobhani, Navid; Ianza, Anna; Roviello, Giandomenico; Mustacchi, Giorgio; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
2023-01-01 Sobhani, Navid; Bouchè, Victoria; Aldegheri, Giovanni; Rocca, Andrea; D’Angelo, Alberto; Giudici, Fabiola; Bottin, Cristina; Donofrio, Carmine Antonio; Pinamonti, Maurizio; Ferrari, Benvenuto; Panni, Stefano; Cominetti, Marika; Aliaga, Jahard; Ungari, Marco; Fioravanti, Antonio; Zanconati, Fabrizio; Generali, Daniele
Avelumab in gastric cancer
2019-01-01 Roviello, G.; D'Angelo, A.; Generali, D.; Pittacolo, M.; Ganzinelli, M.; Iezzi, G.; De Manzini, N.; Sobhani, N.
Bevacizumab in small cell lung cancer
2017-01-01 Roviello, Giandomenico; Sobhani, Navid; Generali, Daniele
Cancer management during the COVID-19 world pandemic
2023-01-01 Sobhani, Navid; Mondani, Giuseppina; Roviello, Giandomenico; Catalano, Martina; Sirico, Marianna; D’Angelo, Alberto; Scaggiante, Bruna; Generali, Daniele
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?
2018-01-01 Sobhani, Navid; Generali, Daniele; Zanconati, Fabrizio; Bortul, Marina; Scaggiante, Bruna
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study
2022-01-01 D'Angelo, Alberto; Giudici, Fabiola; Chapman, Robert; Darlow, Jacob; Kilili, Huseyin; Sobhani, Navid; Cinelli, Mattia; Cappelletti, Maria Rosa; Strina, Carla; Milani, Manuela; Generali, Daniele
Corticosteroid switch after progression on abiraterone acetate plus prednisone
2020-01-01 Roviello, G.; Sobhani, N.; Corona, S.; D'Angelo, A.
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
2021-01-01 Sobhani, Navid; Tardiel-Cyril, Dana Rae; Davtyan, Aram; Generali, Daniele; Roudi, Raheleh; Li, Yong
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer
2018-01-01 Sobhani, Navid; Generali, Daniele; D’Angelo, Alberto; Aieta, Michele; Roviello, Giandomenico
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
2018-01-01 Sobhani, Navid; Ianza, Anna; D'Angelo, Alberto; Roviello, Giandomenico; Giudici, Fabiola; Bortul, Marina; Zanconati, Fabrizio; Bottin, Cristina; Generali, Daniele
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
2018-01-01 Sobhani, Navid; Generali, Daniele; Zanconati, Fabrizio; Bortul, Marina; Scaggiante, Bruna
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma
2017-01-01 Sobhani, Navid; Corona, Silvia P; Zanconati, Fabrizio; Generali, Daniele
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer
2020-01-01 Sirico, M.; Bernocchi, O.; Sobhani, N.; Giudici, F.; Corona, S. P.; Vernieri, C.; Nichetti, F.; Cappelletti, M. R.; Milani, M.; Strina, C.; Cervoni, V.; Barbieri, G.; Ziglioli, N.; Dester, M.; Bianchi, G. V.; Braud, F. D.; Generali, D.
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair
2023-01-01 Ganzinelli, Monica; Guffanti, Federica; Lanza, Anna; Sobhani, Navid; Crovella, Sergio; Zanconati, Fabrizio; Bottin, Cristina; Confalonieri, Marco; Fumagalli, Stefano; Guglielmi, Alessandra; Generali, Daniele; Damia, Giovanna
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5)
2017-01-01 Corona, S. P.; Sobhani, N.; Ianza, A.; Roviello, G.; Mustacchi, G.; Bortul, M.; Zanconati, F.; Generali, D.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
2020-01-01 Schettini, Francesco; Sobhani, Navid; Ianza, Anna; Triulzi, Tiziana; Molteni, Alfredo; Lazzari, Maria Chiara; Strina, Carla; Milani, Manuela; Corona, Silvia Paola; Sirico, Marianna; Bernocchi, Ottavia; Giudici, Fabiola; Cappelletti, Maria Rosaria; Ciruelos, Eva; Jerusalem, Guy; Loi, Sherine; Fox, Stephen B.; Generali, Daniele
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors?
2020-01-01 Sobhani, N.; Corona, S. P.; Roviello, G.; Bagby, S.; D'Angelo, A.; Iezzi, G.; Generali, D.
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses
2023-01-01 D'Angelo, Alberto; Kilili, Huseyin; Chapman, Robert; Generali, Daniele; Tinhofer, Ingeborg; Luminari, Stefano; Donati, Benedetta; Ciarrocchi, Alessia; Giannini, Riccardo; Moretto, Roberto; Cremolini, Chiara; Pietrantonio, Filippo; Sobhani, Navid; Bonazza, Debora; Prins, Robert; Song, Seung Geun; Jeon, Yoon Kyung; Pisignano, Giuseppina; Cinelli, Mattia; Bagby, Stefan; Urrutia, Araxi O